Conception, synthèse et caractérisation de sondes IRM et optiques sensibles aux neurotransmetteurs

Malgré le rôle primordial des neurotransmetteurs (NTs) dans le système nerveux central, leur détection non-invasive in vivo reste un défi majeur. L’imagerie par résonance magnétique (IRM), grâce à son excellente résolution spatiale et temporelle, est parmi les techniques de diagnostic les plus performantes. Elle est au centre des développements récents en imagerie moléculaire. En particulier, l’utilisation des agents d’imagerie intelligents qui sont capables de visualiser le statut physico-chimique des tissus commence à avoir une place importante en neuroscience.Cette étude a pour objectif de concevoir, synthétiser et caractériser in vitro des sondes intelligentes à base de cations lanthanide pour la détection in vivo des NTs. La conception de nos sondes est basée sur des interactions doubles avec des neurotransmetteurs zwitterioniques: d’une part entre le complexes de Ln3+ positivement chargé et le carboxylate du NT et d’autre part entre un ether couronne lié au complexe et la fonction amine du NT. Plusieurs des sondes synthétisées présentent des relaxivités élevées et ont une réponse relaxometrique remarquable aux NTs, bien que leur sélectivité vis-à-vis de l’ion bicarbonate ne soit pas suffisante. Afin de développer des sondes pour une approche bimodale IRM /optique, nous avons également intégré dans les complexes une benzophenone qui joue le rôle de chromophore pour sensibiliser la luminescence des ions Ln3+ émettant dans le proche infra-rouge. Le complexe d’Yb3+ correspondant a des propriétés de luminescence très intéressantes avec une forte réponse aux NTs.In spite of the key role of neurotransmitters (NTs) in signal transduction, their non-invasive in vivo monitoring remains an important challenge. Magnetic resonance imaging (MRI) has recently been demonstrated as a promising technique to non-invasively visualize physiological events with excellent temporal and spatial resolution. In particular, smart MRI contrast agents that are able to report on the physico-chemical status of the tissues, start to have a strong impact in neuroscience. The objective of this work was the design, synthesis and in vitro characterization of a series of lanthanide-based probes responsive to NTs with the aim to track in vivo concentration changes of NTs using MR or optical imaging. The design of our imaging probes relies on a dual binding approach of zwitterionic NTs to the Ln3+ complexes, involving interactions (i) between a positively charged Ln3+ chelate and the carboxylate function of the NTs and (ii) between an azacrown ether appended on the chelate and the amine group of the neurotransmitters. Some of the novel contrast agents were found to exhibit high relaxivities and a remarkable relaxivity response towards NTs, though little selectivity against bicarbonate. In order to apply a bimodal MRI/optical imaging approach, we have also incorporated a benzophenone moiety into the chelate to sensitize the near-infrared emitting Ln3+ ions. The Yb3+ analogue proved to be highly sensitive to NTs

Conception, synthèse et caractérisation de sondes IRM et optiques sensibles aux neurotransmetteurs

In spite of the key role of neurotransmitters (NTs) in signal transduction, their non-invasive in vivo monitoring remains an important challenge. Magnetic resonance imaging (MRI) has recently been demonstrated as a promising technique to non-invasively visualize physiological events with excellent temporal and spatial resolution. In particular, smart MRI contrast agents that are able to report on the physico-chemical status of the tissues, start to have a strong impact in neuroscience. The objective of this work was the design, synthesis and in vitro characterization of a series of lanthanide-based probes responsive to NTs with the aim to track in vivo concentration changes of NTs using MR or optical imaging. The design of our imaging probes relies on a dual binding approach of zwitterionic NTs to the Ln3+ complexes, involving interactions (i) between a positively charged Ln3+ chelate and the carboxylate function of the NTs and (ii) between an azacrown ether appended on the chelate and the amine group of the neurotransmitters. Some of the novel contrast agents were found to exhibit high relaxivities and a remarkable relaxivity response towards NTs, though little selectivity against bicarbonate. In order to apply a bimodal MRI/optical imaging approach, we have also incorporated a benzophenone moiety into the chelate to sensitize the near-infrared emitting Ln3+ ions. The Yb3+ analogue proved to be highly sensitive to NTs.Malgré le rôle primordial des neurotransmetteurs (NTs) dans le système nerveux central, leur détection non-invasive in vivo reste un défi majeur. L’imagerie par résonance magnétique (IRM), grâce à son excellente résolution spatiale et temporelle, est parmi les techniques de diagnostic les plus performantes. Elle est au centre des développements récents en imagerie moléculaire. En particulier, l’utilisation des agents d’imagerie intelligents qui sont capables de visualiser le statut physico-chimique des tissus commence à avoir une place importante en neuroscience.Cette étude a pour objectif de concevoir, synthétiser et caractériser in vitro des sondes intelligentes à base de cations lanthanide pour la détection in vivo des NTs. La conception de nos sondes est basée sur des interactions doubles avec des neurotransmetteurs zwitterioniques: d’une part entre le complexes de Ln3+ positivement chargé et le carboxylate du NT et d’autre part entre un ether couronne lié au complexe et la fonction amine du NT. Plusieurs des sondes synthétisées présentent des relaxivités élevées et ont une réponse relaxometrique remarquable aux NTs, bien que leur sélectivité vis-à-vis de l’ion bicarbonate ne soit pas suffisante. Afin de développer des sondes pour une approche bimodale IRM /optique, nous avons également intégré dans les complexes une benzophenone qui joue le rôle de chromophore pour sensibiliser la luminescence des ions Ln3+ émettant dans le proche infra-rouge. Le complexe d’Yb3+ correspondant a des propriétés de luminescence très intéressantes avec une forte réponse aux NTs

DÉRIVÉS BIFONCTIONNELS DU DO2PA, CHÉLATES AVEC DES CATIONS MÉTALLIQUES ET LEUR UTILISATION

The present invention relates to chelates resulting from the complexation of bifunctional do2pa derivatives ligands of formula (I), wherein the substituents R1, R1', R2, R2', R3, R3', L1, L1', L2 and L2' are defined as in the claims, with metallic cations, especially Pb(II) and Bi(III). The invention further relates to bifunctional do2pa derivatives ligands of formula (I). Another object of the invention is the use of chelates of the invention in nuclear medicine and the use of ligands of the invention in cations detection or epuration of effluents.La présente invention concerne des chélates résultant de la complexation de dérivés bifonctionnels du do2pa en tant que ligands de formule (I), dans laquelle les substituants R1, R1', R2, R2', R3, R3', L1, L1', L2 et L2' sont tels que définis dans les revendications, avec des cations métalliques, en particulier Pb(II) et Bi(III). L'invention concerne également des dérivés bifonctionnels du do2pa en tant que ligands de formule (I). Un autre objet de l'invention concerne l'utilisation des chélates de l'invention en médecine nucléaire et l'utilisation des ligands de l'invention dans la détection de cations ou l'épuration d'effluents

Straightforward and mild deprotection methods of N-mono- and N1,N7-functionalised bisaminal cyclens

International audienceStrategic removal of the bisaminal bridge of N-mono- and N1,N7-difunctionalised cyclen glyoxal derivatives was carried out via transamination processes with vicinal diamines. These procedures were found to be particularly well-suited for cyclen targets bearing sensitive groups

Conception, synthèse et caractérisation de sondes IRM et optiques sensibles aux neurotransmetteurs

Malgré le rôle primordial des neurotransmetteurs (NTs) dans le système nerveux central, leur détection non-invasive in vivo reste un défi majeur. L imagerie par résonance magnétique (IRM), grâce à son excellente résolution spatiale et temporelle, est parmi les techniques de diagnostic les plus performantes. Elle est au centre des développements récents en imagerie moléculaire. En particulier, l utilisation des agents d imagerie intelligents qui sont capables de visualiser le statut physico-chimique des tissus commence à avoir une place importante en neuroscience.Cette étude a pour objectif de concevoir, synthétiser et caractériser in vitro des sondes intelligentes à base de cations lanthanide pour la détection in vivo des NTs. La conception de nos sondes est basée sur des interactions doubles avec des neurotransmetteurs zwitterioniques: d une part entre le complexes de Ln3+ positivement chargé et le carboxylate du NT et d autre part entre un ether couronne lié au complexe et la fonction amine du NT. Plusieurs des sondes synthétisées présentent des relaxivités élevées et ont une réponse relaxometrique remarquable aux NTs, bien que leur sélectivité vis-à-vis de l ion bicarbonate ne soit pas suffisante. Afin de développer des sondes pour une approche bimodale IRM /optique, nous avons également intégré dans les complexes une benzophenone qui joue le rôle de chromophore pour sensibiliser la luminescence des ions Ln3+ émettant dans le proche infra-rouge. Le complexe d Yb3+ correspondant a des propriétés de luminescence très intéressantes avec une forte réponse aux NTs.In spite of the key role of neurotransmitters (NTs) in signal transduction, their non-invasive in vivo monitoring remains an important challenge. Magnetic resonance imaging (MRI) has recently been demonstrated as a promising technique to non-invasively visualize physiological events with excellent temporal and spatial resolution. In particular, smart MRI contrast agents that are able to report on the physico-chemical status of the tissues, start to have a strong impact in neuroscience. The objective of this work was the design, synthesis and in vitro characterization of a series of lanthanide-based probes responsive to NTs with the aim to track in vivo concentration changes of NTs using MR or optical imaging. The design of our imaging probes relies on a dual binding approach of zwitterionic NTs to the Ln3+ complexes, involving interactions (i) between a positively charged Ln3+ chelate and the carboxylate function of the NTs and (ii) between an azacrown ether appended on the chelate and the amine group of the neurotransmitters. Some of the novel contrast agents were found to exhibit high relaxivities and a remarkable relaxivity response towards NTs, though little selectivity against bicarbonate. In order to apply a bimodal MRI/optical imaging approach, we have also incorporated a benzophenone moiety into the chelate to sensitize the near-infrared emitting Ln3+ ions. The Yb3+ analogue proved to be highly sensitive to NTs.ORLEANS-SCD-Bib. electronique (452349901) / SudocSudocFranceF

Macrocyclic Gd(3+) Complexes with Pendant Crown Ethers Designed for Binding Zwitterionic Neurotransmitters.

International audienceA series of Gd(3+) complexes exhibiting a relaxometric response to zwitterionic amino acid neurotransmitters was synthesized. The design concept involves ditopic interactions 1) between a positively charged and coordinatively unsaturated Gd(3+) chelate and the carboxylate group of the neurotransmitters and 2) between an azacrown ether appended to the chelate and the amino group of the neurotransmitters. The chelates differ in the nature and length of the linker connecting the cyclen-type macrocycle that binds the Ln(3+) ion and the crown ether. The complexes are monohydrated, but they exhibit high proton relaxivities (up to 7.7 mM(-1) s(-1) at 60 MHz, 310 K) due to slow molecular tumbling. The formation of ternary complexes with neurotransmitters was monitored by (1) H relaxometric titrations of the Gd(3+) complexes and by luminescence measurements on the Eu(3+) and Tb(3+) analogues at pH 7.4. The remarkable relaxivity decrease (≈80 %) observed on neurotransmitter binding is related to the decrease in the hydration number, as evidenced by luminescence lifetime measurements on the Eu(3+) complexes. These complexes show affinity for amino acid neurotransmitters in the millimolar range, which can be suited to imaging concentrations of synaptically released neurotransmitters. They display good selectivity over non-amino acid neurotransmitters (acetylcholine, serotonin, and noradrenaline) and hydrogenphosphate, but selectivity over hydrogencarbonate was not achieved

H2Me-do2pa: an attractive chelator with fast, stable and inert nat Bi 3+ and 213 Bi 3+ complexation for potential α-radioimmunotherapy applications

International audienceThe complexation properties of H2Me-do2pa towards natBi3+ reveal a rather fast formation of the [Bi(Me-do2pa)]+ complex, which is endowed with a very high thermodynamic stability (log KBiL = 34.2) and presents a single non-fluxional structure in solution. X-ray diffraction and solution NMR studies showed an octadentate binding of the ligand to the metal ion. The labelling of H2Me-do2pa with 213Bi was performed and the resulting complex was stable in vitro, sustaining its use as an attractive alternative to H4dota taken here as a reference

Proflavine derivatives as fluorescent imaging agents of amyloid deposits

A series of proflavine derivatives for use to further image Aβ amyloid deposits were synthesized and characterized. Aged 3xTg-AD (23 months old) mice hippocampus sections incubated with these derivatives revealed preferential labeling of amyloid plaques. Furthermore an in vitro binding study showed an inhibitory effect, although moderate, of these compounds on Aβ40 fibril formation. This study highlights the potential of proflavine as a molecular scaffold for designing new Aβ imaging agents, its native fluorescence allowing in vitro neuropathological staining in AD damaged brain sections.4 page(s

MRI Sensing of Neurotransmitters with a Crown Ether Appended Gd³⁺ Complex

Molecular magnetic resonance imaging (MRI) approaches that detect biomarkers associated with neural activity would allow more direct observation of brain function than current functional MRI based on blood-oxygen-level-dependent contrast. Our objective was to create a synthetic molecular platform with appropriate recognition moieties for zwitterionic neurotransmitters that generate an MR signal change upon neurotransmitter binding. The gadolinium complex (<b>GdL</b>) we report offers ditopic binding for zwitterionic amino acid neurotransmitters, via interactions (i) between the positively charged and coordinatively unsaturated metal center and the carboxylate function and (ii) between a triazacrown ether and the amine group of the neurotransmitters. <b>GdL</b> discriminates zwitterionic neurotransmitters from monoamines. Neurotransmitter binding leads to a remarkable relaxivity change, related to a decrease in hydration number. <b>GdL</b> was successfully used to monitor neural activity in ex vivo mouse brain slices by MRI